Singh Rajneesh Kumar, Kapoor Sorabh, Sahni Peush, Chattopadhyay Tushar K
Department of Gastrointestinal Surgery and Liver Transplantation, All India Institute of Medical Sciences, New Delhi, India.
Ann R Coll Surg Engl. 2007 Jul;89(5):490-3. doi: 10.1308/003588407X202038.
Haemangioma is the most common liver tumour. Treatment is indicated for symptomatic tumours, rapid increase in size, rupture or doubt in diagnosis. There is continuing debate regarding the ideal method of surgical treatment for liver haemangiomas, with some surgeons favouring enucleation over liver resection.
Retrospective analysis of prospectively compiled database of patients who were surgically treated for liver haemangioma.
Between 1987 and 2003, we operated on 21 patients with liver haemangioma. Pre-operative diagnosis on imaging was made in 16 patients (13 symptomatic, 3 had progressive increase in size). In five patients, the indication of surgery was uncertain diagnosis. Enucleation was performed in 9 patients and liver resection in 12. The size of the haemangioma was similar in the enucleation and resection groups (8.9 cm versus 10 cm; P = 0.85). The mean intra-operatiive blood loss was significantly less in the enucleation group (400 ml versus 1330 ml; P = 0.004). The mean operative time was significantly less in the enucleation group as compared to the resection group (170 min versus 230 min; P = 0.035). Five patients had major postoperative morbidity in the resection group as compared to none in the enucleation group (P = 0.045). The duration of hospital stay was significantly longer in the resection group.(9.9 days versus 5.6 days; P = 0.005).
Enucleation of liver haemangiomas is safer, quicker and associated with less morbidity than liver resection. Except for some situations, such as uncertain diagnosis or total replacement of a lobe, we recommend enucleation as the surgical procedures of choice for the treatment of hepatic haemangiomas.
肝血管瘤是最常见的肝脏肿瘤。有症状的肿瘤、体积迅速增大、破裂或诊断存疑时需进行治疗。关于肝血管瘤手术治疗的理想方法一直存在争议,一些外科医生更倾向于采用摘除术而非肝切除术。
对前瞻性收集的接受肝血管瘤手术治疗患者的数据库进行回顾性分析。
1987年至2003年间,我们为21例肝血管瘤患者实施了手术。16例患者(13例有症状,3例体积逐渐增大)术前通过影像学做出诊断。5例患者手术指征为诊断不确定。9例行摘除术,12例行肝切除术。摘除术组和切除术组的血管瘤大小相似(8.9厘米对10厘米;P = 0.85)。摘除术组术中平均失血量显著少于切除术组(400毫升对1330毫升;P = 0.004)。与切除术组相比,摘除术组平均手术时间显著更短(170分钟对230分钟;P = 0.035)。切除术组有5例患者术后出现严重并发症,而摘除术组无(P = 0.045)。切除术组住院时间显著更长(9.9天对5.6天;P = 0.005)。
肝血管瘤摘除术比肝切除术更安全、更快,且并发症更少。除了某些情况,如诊断不确定或一个肝叶完全被替代,我们推荐摘除术作为治疗肝血管瘤的首选手术方式。